The relationship between dose, route of administration, and clinical outcomes requires systematic investigation to establish therapeutic ranges and maximize efficacy while minimizing potential risks
doi: 10.3389/fneur.2026.1788148 Received 15 January 2026 Revised 16 February 2026 Accepted 23 February 2026 Published 07 April 2026 Volume 17 - 2026 Edited by Paul Chazot, Durham University, United Kingdom Reviewed by Li Baojian, Shaanxi University of Chinese Medicine, China Ayokunmi Akinduko, Landmark University, Nigeria Updates Copyright 2026 Okomolo Moto, Diapa Tchiengang, Kameni Njapdounke, Mbom, Mbeboh Savo, Aren Arsaa, Nezoumne, Ndjock and Bum
Ledda C, Cannizzaro E, Cin D, Filetti V, Vitale E, Paravizzini G, et al
Frequently Asked Questions What is the standard KPV peptide dosage